Jeremy Grantham Novartis Ag Transaction History

Grantham, Mayo, Van Otterloo & Co. LLC

$31.4 Billion
Q3 2024

A detailed history of Jeremy Grantham (Grantham, Mayo, Van Otterloo & Co. LLC) transactions in Novartis Ag stock. As of the latest transaction made, Grantham, Mayo, Van Otterloo & Co. LLC holds 665,019 shares of NVS stock, worth $65.5 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

665,019

Previous 779,681 14.71%

Holding current value

$65.5 Million

Previous $83 Million 7.85%

% of portfolio

0.24%

Previous 0.28%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $12.2 Million - $13.9 Million	-114,662 Reduced 14.71%	665,019 $76.5 Million
Q2 2024 Aug 13, 2024	SELL	$92.57 - $107.37 $15.4 Million - $17.8 Million	-166,195 Reduced 17.57%	779,681 $83 Million
Q1 2024 May 14, 2024	SELL	$95.27 - $108.47 $55.4 Million - $63.1 Million	-581,499 Reduced 38.07%	945,876 $91.5 Million
Q4 2023 Feb 13, 2024	SELL	$92.27 - $101.54 $27.7 Million - $30.5 Million	-299,888 Reduced 16.41%	1,527,375 $154 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $108 Million - $120 Million	1,144,307 Added 167.55%	1,827,263 $186 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $62.2 Million - $70.6 Million	672,756 Added 6595.65%	682,956 $68.9 Million
Q1 2023 May 12, 2023	SELL	$80.03 - $92.81 $2.79 Million - $3.23 Million	-34,800 Reduced 77.33%	10,200 $938,000
Q4 2022 Feb 13, 2023	BUY	$75.55 - $92.52 $3.4 Million - $4.16 Million	45,000 New	45,000 $4.08 Million
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $281,820 - $328,125	-3,500 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $15.4 Million - $17.4 Million	-192,200 Reduced 98.21%	3,500 $307,000
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $2.61 Million - $2.89 Million	32,800 Added 20.14%	195,700 $17.1 Million
Q3 2021 Nov 12, 2021	BUY	$81.78 - $95.14 $13.1 Million - $15.2 Million	159,900 Added 5330.0%	162,900 $13.3 Million
Q2 2021 Aug 12, 2021	BUY	$85.24 - $94.15 $255,719 - $282,450	3,000 New	3,000 $274,000
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $384,930 - $424,170	-4,500 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $120,640 - $148,480	-1,600 Reduced 26.23%	4,500 $411,000
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $331,407 - $379,060	-4,400 Reduced 41.9%	6,100 $586,000
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $486,156 - $541,332	-6,600 Reduced 38.6%	10,500 $901,000
Q3 2018 Nov 14, 2018	SELL	$66.94 - $77.43 $160,656 - $185,832	-2,400 Reduced 12.31%	17,100 $1.47 Million
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $1.27 Million - $1.43 Million	19,500 New	19,500 $1.47 Million

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track Jeremy Grantham's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grantham, Mayo, Van Otterloo & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grantham, Mayo, Van Otterloo & Co. LLC and Jeremy Grantham with notifications on news.

Account